Vicente played a key role in passing
Colorado Amendment 64, a
ballot initiative to legalize, regulate, and tax the sale of marijuana to adults 21 or older. Founding partner
Brian Vicente was a co-author of Amendment 64 and the law firm's office served as the campaign headquarters. The firm also has played a significant role in advising national, state and local government officials in the development of regulated cannabis markets across the country and around the world, including Uruguay, the first country in the world to legalize and regulate marijuana for adult use. Firm founding partner Christian Sederberg is a Colorado lobbyist who worked on former Colorado Governor
John Hickenlooper's Amendment 64 Implementation Task force and the Committee for Responsible Regulation, and other committees and associations. Founding partner Joshua Kappel co-authored Colorado's Proposition 122, the Natural Medicine Health Act of 2022, and served as chair of the campaign committee for Natural Medicine Colorado. Proposition 122 was passed by Colorado voters in November 2022. He is actively involved in the development and implementation of the NMHA (including Colorado's SB23-290) and other psychedelics laws and policies in the U.S. and abroad. In addition, Joshua is a founding board member of the Microdosing Collective—the only recognized nonprofit in the U.S. dedicated to legalizing microdosing. Vicente's Hemp and Cannabinoids Practice Chair, partner Shawn Hauser, is a steering committee member of the American Hemp Campaign, and was the lead author of the 2018 Farm Bill Policy Guide and Model Hemp Production Plan]. She has testified before the U.S. Food & Drug Administration on behalf of the hemp industry. Vicente was the law firm that provided counsel for the Hemp Industries Association (HIA) in its case against the Drug Enforcement Administration (DEA) in October 2020, where the HIA and a hemp product manufacturer filed a lawsuit against the DEA to challenge the agency's "interim final rule" on hemp production. The lawsuit argued that the DEA's rule improperly classified certain hemp extracts as Schedule I controlled substances, even if the final product contained a legal level of THC. The court ultimately sided with the DEA, though the DEA has not actively enforced the rule. ==In the media==